Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO), has been at the forefront of biologic development and manufacturing for over 40 years. Our value chain encompasses the whole process: from gene to vial and from concept to market. As a full-service provider, Rentschler Biopharma offers its clients one primary contact, with only one contract signed for all phases of a development cycle. As a provider of high-end solutions for our partners, we help clients transition a project from genetic engineering all the way through fill and finish. Projects are supported by analytical method development and validation, formulation development, and the elaboration of optimal global regulatory approval strategies from the very beginning, through clinical studies up to market approval.

Fill out the form below to read the complete capabilities review now.